Synovial sarcoma

References

• de Alva E, Kawai A, Healey J H, Fligman I, Meyers P A, Huvos A G, Gerald W L, Jhanwar S C, Argani P. Anto-nescu C R, Pardo-Mindan F J, Ginsberg J, Womer R, Lawlar E R, Wunder J, Andrulis I, Sorensen P H B, Barr F G, Ladanyi M. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing' s sarcoma. J Clin Oncol 1998; 16: 1248–55.
   Google Scholar
• Bergh P, Meis-Kindblom J M, Gherlinzoni F, Berlin 6, Bacchini P, Bertoni F, Gunterberg B, Kindblom L-G. Synovial sarcoma. Identification of high and low risk groups. Submitted to Cancer.
   Google Scholar
• Brett D, Whitehouse S, Antonson P, Shipley J, Cooper C, Goodwin G. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional acti-vator localised in nuclear bodies. Hum. Mol. Genet; 1997: 6: 1559–64.
   PubMed Web of Science ®Google Scholar
• Broders A C, Hargrave R, Meyerding H W. Pathological features of soft tissue fibrosarcoma with special refer-ence to the grading of its malignancy. Surg Gynecol Ob-stet 1939; 69: 267–80.
   Google Scholar
• Brodsky J T, Burt M E, Hajdu S I, Casper E S, Brennan M F. Tendosynovial sarcoma. Clinicopathologic features, treatment, and prognosis. Cancer 1992; 70: 484–9.
   Google Scholar
• Brown D C, Gatter K C. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990; 17: 489–503.
   PubMed Web of Science ®Google Scholar
• de Bruijn D H R, Baats E, Zechner U, De Leeuw B, Bale-mans M, Olde-Weghuis D, Hirning-Folz U, van Kessel A. Isolation and characterization of the mouse homolog of SYT, a gene implicated in the development of human synovial sarcoma. Oncogene 1996; 13: 643–8.
   PubMed Web of Science ®Google Scholar
• Boel P, Wildmann C, Sensi, M L, Brasseur R, Renauld J C, Coulie P, Boon T, van der Bruggen P. BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 1995; 2: 167–75.
   Google Scholar
• Cadman N L, Soule E H, Kelly P J. Synovial sarcoma. Can-cer 1965; 18: 613–23.
   Google Scholar
• Cagle LA, Mirra J M, Storm K, Roe D J, Eilber F R. Histo-logic Fetaures Relating to Prognosis in Synovial Sarco-ma. Cancer 1987; 59: 1910–4.
   Web of Science ®Google Scholar
• Cameron H U, Kostuik J P. A long-term follow-up of syn-ovial sarcoma. J Bone Joint Surg Am 1974; 56B: 613–7.
   Web of Science ®Google Scholar
• Cattoretti G, Becker M H G, Key G, Duchrow M, Schluter C, Galle J, Gerdes J. Monoclonal antibodies against re-combinant parts of the Ki-67 antigen (M1B1 and MIB3) detect proliferating cells in microwave-processed for-malin-fixed paraffin sections. J Pathol 1992; 168: 357–63.
   PubMed Web of Science ®Google Scholar
• Choong P F M, Pritchard D J, Sim F H, Rock M G, Nasci-mento A G. Long-term survival in high grade soft tissue sarcoma: prognostic factors in synovial sarcoma. Int J Oncol 1995; 7: 161–9.
   PubMed Web of Science ®Google Scholar
• Clark J, Rocques P J, Crew A J, Gill S, Shipley J, Chan A M. Identification of novel genes, SYT and SSX, in-volved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat Genet 1994; 7: 502–8.
   Google Scholar
• Cordon-Cardo C, Latres E, Drobnjak M, Oliva M R, Pollak D, Woodruff J M, Marechal V, Chen J, Brennan M F, Levine A J. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994; 54: 794–9.
   Google Scholar
• Crew A J, Clark J, Fisher C, Gill S, Grimer R, Chand A. Fusion of SYT to two genes, SSX1 and 55X2, encoding proteins with homology to the Kruppel- associated box in human synovial sarcoma. EMBO J 1995; 14: 2333–40.
   PubMed Web of Science ®Google Scholar
• Drobnjak M, Latres E, Pollak D, Karpeh M, Dudas M, Woodruff J M, Brennan M F, Cordon-Cardo C. Prognos-tic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarco-mas. JNCI 1994; 86: 549–54.
   Google Scholar
• Ellis P S J, Whitehead R. Mitosis counting : a need for re-appraisel. Hum Pathol 1981; 12: 3–4.
   PubMed Web of Science ®Google Scholar
• El-Naggar A K, Ayala A G, Abdul-Karim F W, McLemore D, Ballance W W, Garney L, Ro J Y, Batsakis J G. Syn-ovial sarcoma. A DNA flow cytometric study. Cancer 1990; 65: 2295–300.
   Google Scholar
• El-Rifai W, Larramendy M L, Björkvist A, Hemmer S, Kn-uutila S. Optimization of comparative genomic hybrid-ization using fluorochrome conjugated to dCTP and dUTP. Lab Invest 1997; 77: 699–700.
   Google Scholar
• Enneking W F, Spanier S S, Goodman M A. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980; 153: 106–20.
   PubMed Web of Science ®Google Scholar
• Enzinger F M and Weiss S W. Soft tissue tumors. 3' ed. C V Mosby Co, St Louis, Toronto, London 1995.
   Google Scholar
• Fligman I, Lonardo F, Jhanwar S C, Gerald W L, Woodruff J, Ladanyi M. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-55X2 fusion tran-script. A J P 1995; 147: 1592–9.
   Google Scholar
• Folpe A L, Schmidt R A, Chapman D, Gown A M. Poorly differentiated synovial sarcoma. Immunohistochemica 1 distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol. 1998; 22: 673–82.
   Google Scholar
• Gerdes J, Lemke H, Baisch H, Wacker H H, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-asso-ciated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710–5.
   Google Scholar
• Gerdes J, Becker M H G, Key G. Immunohistochemica 1 detection of tumor growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 1992; 168: 85–7.
   PubMed Web of Science ®Google Scholar
• Golouh R, Vuzevski V, Bracko M, van der Heul R O, Cervek J. Synovial sarcoma: a clinicopathological study of 36 cases. J Surg Oncol 1990; 45: 20–8.
   Google Scholar
• Gure A O, Tureci 6, Sahin U, Tsang S, Scanlan M J, Jager E, Knuth A, Pfreundschuh M, Old L J, Chen Y-T. SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer 1997; 72: 965–71.
   Google Scholar
• Gustafson P, Dreinhöfer K E, Rydholm A. Soft tissue sar-coma should be treated at a tumor center. A comparison of quality of surgery in 375 patients. Acta Orthop Scand 1994; 1:47–50.
   Web of Science ®Google Scholar
• Gustafson P. Soft tissue sarcoma. Acta Orthop Scand. (Suppl 259) 1994; 65: 1–31.
   PubMedGoogle Scholar
• Haagensen C D, Staut A P. Synovial sarcoma. Ann Surg 1944; 120: 826–42.
   PubMedGoogle Scholar
• Hajdu S I, Shui M H, Fortner J G. Tendosynovial sarcoma. Cancer 1977; 39: 1201–17.
   PubMed Web of Science ®Google Scholar
• Heslin M J, Cordon-Cardo C, Lewis J J, Woodruff J M, Brennan M F. Ki-67 detected by M1B-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma. Cancer 1998; 83: 490–7.
   PubMed Web of Science ®Google Scholar
• Janz M, De Leeuw B, Weghuis D O, Werner M, Nolte M, Geurts van Kessel A. Interphase cytogenetic analysis of distinct X-chromosomal translocation breakpoints in synovial sarcoma. J Pathol 1995; 175: 391–6.
   PubMed Web of Science ®Google Scholar
• Kallioniemi O P, Kallioniemi A, Piper J, Isola J, Waldman F M, Gray J W, Pinkel D. Optimizing comparative ge-nomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosom Cancer 1994; 10: 231–43.
   Google Scholar
• Kampe C E, Rosen G, Eilber F, Eckardt J, Lowenbraun S, Foster J, Forscher C, Selch M. Synovial sarcoma. A study of intensive chemotherapy in 14 patients with lo-calized disease. Cancer 1993; 72: 2161–9.
   Google Scholar
• Kawai A, Woodruff J, Healey J H, Brennan M, Antonescu C, Ladanyi M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N Engl J Med 1998; 338: 153–60.
   PubMed Web of Science ®Google Scholar
• Ladenstein R, Treuner J, Koscielniak E, d Oleire F, Keim M. Synovial sarcoma of childhood and adolescence. Re-port of the German CWS-81 study. Cancer 1993; 71: 3647–55.
   Google Scholar
• de Leeuw B, Suijkerbuijk R F, Olde Weghuis D, Meloni A M. Distinct Xp11.2 breakpoint regions in synovial sar-coma revealed by metaphase and interphase FISH: rela-tionship to histologic subtypes. Cancer Genet Cytogenet 1994; 73: 89–94.
   Google Scholar
• de Leeuw B, Balemans M, Olde Weghuis D, Geurts van Kessel A. Identification of two alternative fusion genes, SYT-SSX1 and SYT-55X2, in t(X;18)(p11.2;q11.2) - positive synovial sarcomas. Hum Mol Genet 1995; 6: 1097–9.
   Google Scholar
• de Leeuw B, Balemans M, Geurts van Kessel A. A novel Kr:uppel-associated box containing the SSX gene (55X3) on the human X chromosome is not implicated in t(X;18)-positive synovial sarcomas. Cytogenet Cell Genet 1996; 73: 179–83.
   Google Scholar
• Levine E A, Holzmayer T, Bacus S, Mechetner E, Mera R, Bolliger C, Roninson I B, Das Gupka T K. Evaluation of newer prognostic markers for adult soft tissue sarcoma. J Clin Oncol 1997; 15: 3249–57.
   Google Scholar
• Licht J D, Ro M, English M A, Grossel M, Hansen U. Se-lective repression of transcriptional activators at a dis-tance by the Drosphila Kruppel protein. Natl Acad Sci USA 1993; 90: 11361–5.
   Google Scholar
• Lim FL, Soulez M, Koczan D, Thiesen H-J, Knight J C. A KRAB-related domain and a novel transcription repres-sor domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene 1998; 17: 2013–8.
   Google Scholar
• Limon J, Dal Cin P, Sandberg A A. Translocation involving the X chromosome in solid tumors : Presentation of two sarcomas with the t(X;18) (q13,p11). Cancer Genet Cy-togenet 1986; 23: 87–91.
   PubMedGoogle Scholar
• Mandahl N. Genetics of bone and soft tissue tumors. Adv cancer Res 1996; 69: 63–99.
   PubMed Web of Science ®Google Scholar
• Mankin H, Mankin C, Simon M. The hazards of biopsy re-visited. For the members of the Musculoskeletal Tumor Society. J Bone Joint Surg 1996; 78-A: 656–63.
   Google Scholar
• Meis-Kindblom J M, Stenman G, Kindblom L-G. Differen-tial diagnosis of small round cell tumors. Semin Diagn Pathol. 1996;13: 213–41.
   PubMed Web of Science ®Google Scholar
• Meis-Kindblom J M, Kindblom L-G. Angiosarcoma in soft tissue: a study of 80 cases. Am J Surg Pathol 1998; 6: 683–97.
   Google Scholar
• Melo J V. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88: 2375–84.
   PubMed Web of Science ®Google Scholar
• Menendez L R, Brien E, Brien WW. Synovial sarcoma. A clinicopathologic study. Orthop Rev 1992; 21(4): 465–71.
   Google Scholar
• Mitchell P J, Tijan R. Transcriptional regulation in mam-malian cells by sequence-specific DNA binding pro-teins. Science 1989; 245: 371–8.
   PubMed Web of Science ®Google Scholar
• Moberger G, Nilsonne U, Friberg S. Synovial sarcoma. Acta Orthop Scand 1968; 111:3–38.
   Google Scholar
• Mullen J R, Zagars G K. Synovial sarcoma outcome fol-lowing conservation surgery and radiotherapy. Radioth-er Oncol 1994; 33: 23–30.
   PubMed Web of Science ®Google Scholar
• Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Man-dahl N, Lundeberg J, Uhlén M, Larsson O. The SYT-SSX1 Variant of Synovial Sarcoma is Associated with High Rate of Tumor Cell Proliferation and Poor Clinical Outcome. Cancer Res 1999; 59:3180–4.
   Google Scholar
• Oda Y, Hashimoto H, Tsuneyoshi M, Takeshita S. Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison be-tween early death and long-term survival. Am J Surg Pathol 1993; 17: 35–44.
   Google Scholar
• Pack G T, Ariel I M. Synovial sarcoma (malignant synovio-ma). A report of 60 cases. Surgery 1950; 28: 1047–84.
   Google Scholar
• Rosen G, Forscher C, Lowenbraun S, Eilber F, Eckardt J. Synovial sarcoma. Uniform response of metastases to high dose ifosfamide. Cancer 1994; 73: 2506–11.
   Google Scholar
• Rooser B, Willén H, Hugosson A, Rydholm A. Prognostic factors in synovial sarcoma. Cancer 1989; 63: 2182–5.
   PubMed Web of Science ®Google Scholar
• dos Santos N R, de Bruijn D R H, Balemans M, Janssen B, Gartner F, Lopes J M, de Leeuw B, Geurts van Kessel A. Nuclear localization of SYT, SSX and the synovial sar-coma- associated SYT-SSX fusion proteins. Hum Mol Genet 1997; 6: 1549–58.
   Google Scholar
• Shi R-R, Key M E, Kalra K L. Antigen retrieval in forma-lin-fixed, paraffin-embedded tissues an enhancement method for immunohistochemical staining based on mi-crowave oven heating of tissue sections. Histochem Cy-tochem 1991; 39: 741–8.
   Google Scholar
• Shirakawa H, Tsuda K, Yoshida M. Primary structure of non-histotone chromosomal protein HMG2 revealed by the nucleotide sequence. Biochemistry 1990; 29: 4419–23.
   Google Scholar
• Singer S, Baldini E H, Demetri G D, Fletcher J A, Corson J M. Synovial sarcoma: prognostic significance of tumor size, margin of resection, and mitotic activity for surviv-al. J Clin Oncol 1996; 14: 1201–8.
   PubMed Web of Science ®Google Scholar
• Skytting B T, Bauer H C F, Perfekt R, Huuhtanen R, Alveg-fird T, Berlin 6, Gustafson P. Klepp R, Löfvenborg R, Swter G, Trovik C, Wahlström O. Clinical Course in Synovial Sarcoma: a Scandinavian Sarcoma Group Study of 104 Patients. Acta Orthop Scand 1999; 70 (6): 536–42.
   Google Scholar
• Skytting B T, Meis-Kindblom J M, Larsson O, Virolainen M, Perfekt R, Akerman M, Kindblom L-G. Synovial Sarcoma: Identification of Favorable and Unfavorable Histologic Types — A Scandinavian Sarcoma Group Study of 104 Cases. Acta Orthop Scand 1999; 70 (6): 543–54.
   PubMedGoogle Scholar
• Skytting B T, Bauer H C F, Perfekt R, Nilsson G, Larsson O. Ki-67 is Strongly Prognostic in Synovial Sarcoma. Analysis Based on 86 Patients from the Scandinavian Sarcoma Group Register. Br J Cancer 1999; 80:1809–14.
   Google Scholar
• Skytting B T, Szymanska J, Aalto Y, Lushnikova T, Blom-qvist C, Elomaa I, Larsson O, Knuutila S. Clinical Im-portance of Secondary Aberrations in Synovial Sarcoma Evaluated by Comparative Genomic Hybridization. Cancer Genet Cytogenet 1999; 115: 39–46.
   Google Scholar
• Skytting B, Nilsson G, Brodin B, Xie Y, Lundborg J, Uhlen M, Larsson O. A novel fusion gene, SYT-55X4, in syn-ovial sacoma. J Natl Cancer Inst 1999; 91: 974–5.
   PubMedGoogle Scholar
• Szymanska J, Serra M, Skytting B, Larsson O, Virolainen M, Akerman M, Tarkkanen M, Huuhtanen, Picci P, Bac-chini P, Asko-Seljavaara S, Eloma I, Knuutila S. Genetic Imbalances in 67 Synovial Sarcomas Evaluated by Comparative Genomic Hybridization. Genes, Chromo-somes & Cancer 1998; 23: 213–9.
   PubMed Web of Science ®Google Scholar
• Turc-Carel C, Dal Cin P, Limon J, Li F, Sandberg A. Trans-location X;18 in synovial sarcoma. Cancer Genet Cyto-genet 1986; 23: 93.
   Google Scholar
• Tureci O, Sahin U, Schobert I, Koslowski M, Schmitt H, Schild H-J, Stenner F, Seitz G, Rammensee H-G, Pfre-undschuh M. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res 1996; 56: 4766–72.
   Google Scholar
• Wadayama B, Toguchida J, Yamaguchi T, Sasaki M S, Ko-toura Y, Yamamuro T. P53 expression and its relation-ship to DNA alterations in bone and soft tissue sarco-mas. Br. J Cancer 1993; 68: 1134–9.
   Google Scholar
• van de Rijn M, Barr F G, Xiong Q-B, Hedges M, Shipley J, Fisher C. Poorly differentiated synovial sarcoma. An analysis of clinical, pathologic, and molecular genetic features. Am J Surg Pathol 1999; 23: 106–12.
   Web of Science ®Google Scholar
• van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T. A gene encoding an antigen recognized by cytolytic T lympho-cytes on a human melanoma. Science 1991; 254: 1643–7.
   PubMed Web of Science ®Google Scholar
• Varela-Duran J, Enzinger F M. Calcifying synovial sarco-ma. Cancer 1982; 50: 345–52.
   PubMed Web of Science ®Google Scholar
• Wright P H, Sim F H, Soule E H, Taylor W F. Synovial sarcoma. J Bone Joint Surg Am 1982; 64: 112–22.
   PubMed Web of Science ®Google Scholar
• Wurl P, Taubert H, Meye A, Berger D, Lautenschläger C, Holzhausen H-J, Schmidt H, Kalthoff H, Rath F-W, Dralle H. Prognostic value of immunohistochemistry for p53 in primary soft tissue sarcomas: a multivariate anal-ysis of five antibodies. J Cancer Res Oncol. 1987; 123: 502–8.
   Google Scholar
• Zehr R J, Bauer T W, Marks K E, Weltevreden A. Ki-67 and grading of malignant fibrous histocytomas. Cancer 1990; 66: 1984–90.
   PubMed Web of Science ®Google Scholar
• Zito R A. Synovial sarcoma: an Australian series of 48 cas-es. Pathology 1984; 16: 45–52.
   PubMed Web of Science ®Google Scholar
• Zoubek A, Dockhorn-Dworniczak B, Delattre O, Chris-tiansen H, Niggli F, Gatter-Menz I, Smith T L, Jiirgens H, Gadner H, Kovar H. Does Expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients? J Clin Oncol 1996; 14: 1245–51.
   PubMed Web of Science ®Google Scholar